You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

Completed
Has Results
  • Age-Related Maculopathy
  • +4 more
  • RN6G
  • Placebo
  • Campbell, California
  • +23 more
May 10, 2022

Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

Completed
  • Age-Related Macular Degeneration
  • OpRegen
  • (no location specified)
Nov 1, 2022

Dry Age-related Macular Degeneration Trial in Ann Arbor (RPESC-RPE-4W)

Recruiting
  • Dry Age-related Macular Degeneration
  • RPESC-RPE-4W
  • Ann Arbor, Michigan
    University of Michigan Kellogg Eye Center
Jan 27, 2023

Geographic Atrophy Insights (i-GAIN) Natural History Study

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
    • Belfast, United Kingdom
    • +11 more
    Mar 22, 2023

    Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

    Recruiting
    • Age-related Macular Degeneration
    • Geographic Atrophy
    • VOY-101
    • Bellaire, Texas
      Retina Consultants of Texas
    Nov 17, 2022

    Geographic Atrophy Trial in Bellaire, Dallas (OCU410)

    Recruiting
    • Geographic Atrophy
    • OCU410
    • Bellaire, Texas
    • +1 more
    Aug 25, 2023

    Healthy Volunteer, Dry Age-related Macular Degeneration Trial (Tinlarebant (LBS-008))

    Not yet recruiting
    • Healthy Volunteer
    • Dry Age-related Macular Degeneration
    • Tinlarebant (LBS-008)
    • (no location specified)
    Dec 19, 2022

    Macular Degeneration, Senile, Laser Burn of Retina, Macular Degeneration Intermediate Trial in Genova, Milan, Rome (Pascal

    Recruiting
    • Macular Degeneration, Senile
    • +3 more
    • Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)
    • Pascal Synthesis 577 sham (Topcon Corporation, Tokyo, Japan)
    • Genova, Italy
    • +3 more
    Jul 27, 2022

    Macular Degeneration Trial in United Kingdom, United States (BI 754132)

    Terminated
    • Macular Degeneration
    • BI 754132
    • Beverly Hills, California
    • +12 more
    Aug 23, 2022

    Dry Age-related Macular Degeneration Trial in Boston (AAVCAGsCD59)

    Completed
    • Dry Age-related Macular Degeneration
    • AAVCAGsCD59
    • Boston, Massachusetts
      Ophthalmic Consultants of Boston
    Mar 30, 2021

    Dry Age-related Macular Degeneration, Geographic Atrophy, Gene Therapy Trial (Intravitreal AAVCAGsCD59, Intravitreal Sham

    Withdrawn
    • Dry Age-related Macular Degeneration
    • +3 more
    • Intravitreal AAVCAGsCD59
    • Intravitreal Sham Injection
    • (no location specified)
    May 6, 2021

    Dry Age Related Macular Degeneration Trial in United States (MA09-hRPE)

    Completed
    • Dry Age Related Macular Degeneration
    • MA09-hRPE
    • Los Angeles, California
    • +3 more
    Jul 4, 2021

    Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

    Terminated
    • Wet Age-related Macular Degeneration
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Nov 1, 2022

    Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

    Recruiting
    • Eye Diseases
    • +2 more
    • Pars plana vitrectomy
    • +3 more
    • Chelmsford, Essex, United Kingdom
    • +13 more
    Aug 2, 2022

    Geographic Atrophy Trial in Melbourne (ONL1204 Ophthalmic solution, sham injection)

    Recruiting
    • Geographic Atrophy
    • ONL1204 Ophthalmic solution
    • sham injection
    • Melbourne, Victoria, Australia
      Center for Eye Rearch Australia
    Jul 29, 2021

    Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
    • GT005
    • Saint Petersburg, Florida
    • +12 more
    Dec 21, 2021

    Neovascular Age-related Macular Degeneration Trial in Worldwide (brolucizumab)

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • Huntington Beach, California
    • +59 more
    Jan 20, 2023

    Dry Age-related Macular Degeneration Trial in Worldwide (GT005: Medium Dose, GT005: High Dose)

    Active, not recruiting
    • Dry Age-related Macular Degeneration
    • GT005: Medium Dose
    • GT005: High Dose
    • Phoenix, Arizona
    • +61 more
    Dec 14, 2022

    Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)

    Terminated
    Has Results
    • Choroidal Neovascularization
    • Wet Macular Degeneration
    • ICON-1
    • aflibercept
    • Beverly Hills, California
    • +7 more
    Mar 21, 2021

    Neovascular (Wet) Age-related Macular Degeneration (AMD) Trial in United Kingdom (Stereotactic radiotherapy (16 Gray or Sham),

    Active, not recruiting
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Stereotactic radiotherapy (16 Gray or Sham)
    • 0.5 mg ranibizumab
    • Huntingdon, Cambridgeshire, United Kingdom
    • +29 more
    Apr 1, 2022

    Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

    Recruiting
    • Macular Degeneration
    • Geographic Atrophy
    • Phoenix, Arizona
    • +83 more
    Aug 19, 2022

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Completed
    • Dry Age-related Macular Degeneration
    • +4 more
    • GEM103
    • Phoenix, Arizona
    • +11 more
    Feb 9, 2021

    Age-related Macular Degeneration, Dementia, Low Vision Trial in Longueuil, Montreal (Low Vision Reading Rehabilitation)

    Suspended
    • Age-related Macular Degeneration
    • +6 more
    • Low Vision Reading Rehabilitation
    • Longueuil, Quebec, Canada
    • +1 more
    Mar 14, 2021

    Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

    Completed
    Has Results
    • Macular Degeneration
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Wien, Austria
    • +70 more
    Jun 1, 2021

    Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,

    Recruiting
    • Age-Related Macular Degeneration
    • Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
    • Sham Mask
    • Paris, France
    • +6 more
    Sep 14, 2023